70 likes | 80 Views
Global Evidence of Comparative Efficiency: Performance of National HIV/AIDS Programs. Donald S. Shepard, PhD Wu Zeng, MD, PhD Jon Chilingerian, PhD Carlos Avila-Figueroa, MD, ScD Presented to the Global Fund for AIDS, Tuberculosis, and Malaria Geneva, Switzerland April 13, 2011
E N D
Global Evidence of Comparative Efficiency:Performance ofNational HIV/AIDS Programs Donald S. Shepard, PhD Wu Zeng, MD, PhD Jon Chilingerian, PhD Carlos Avila-Figueroa, MD, ScD Presented to the Global Fund for AIDS, Tuberculosis, and Malaria Geneva, Switzerland April 13, 2011 Schneider Institutes for Health Policy, Heller School Brandeis University, Waltham, MA 02454-9110 USA Supported by UNAIDS
Outline • Background • Component I: Performance of national HIV/AIDS programs • Component II: Determinants of efficiency of national HIV/AIDS programs • Conclusions and limitations
Framework Production unit (e.g. national AIDS program) Output(s) Input(s) 3
Component I: Performance of national HIV/AIDS programs • Objective: To evaluate the efficiency of national HIV/AIDS programs • Methods: Data envelopment analysis (DEA) • Input: Total national spending on HIV/AIDS • Outputs: • Number of people receiving voluntary counseling and testing (VCT) • Number of HIV+ pregnant women receiving HIV/AIDS treatment for prevention from mother to children transmission (PMTCT) • Number of AIDS patients receiving ARV treatment (ART)
Efficient? Production unit (e.g. national AIDS program) Output(s) Input(s) 5
Data sources: country-years by variable (Total: 151 country years, covering 68 countries, 2002-2007)